- UNLOCKING THE POTENTIAL OF PLASMID-BASED ANTIBODY GENE TRANSFER(2021)
Auteurs: Giles Vermeire, Paul Declerck, Kevin Hollevoet
- Improved Potency and Safety of DNA-Encoded Antibody Therapeutics Through Plasmid Backbone and Expression Cassette Engineering(2021)
Auteurs: Giles Vermeire, Nick Geukens, Paul Declerck, Kevin Hollevoet
Pagina's: 1200 - 1209
- DNA-based delivery of anti-DR5 Nanobodies improves exposure and anti-tumor efficacy over protein-based administration(2021)
Auteurs: Giles Vermeire, Nick Geukens, Paul Declerck, Kevin Hollevoet
Pagina's: 828 - 838
- Building a Versatile and Clinically Translatable Platform for DNA-Based Antibody Therapeutics(2020)
Auteurs: Kevin Hollevoet, Elien De Smidt, Giles Vermeire, Liesl Jacobs, Stephanie De Vleeschauwer, Nick Geukens, Paul Declerck
Pagina's: 237 - 238
- Bridging the Clinical Gap for DNA-Based Antibody Therapy Through Translational Studies in Sheep(2019)
Auteurs: Kevin Hollevoet, Stéphanie De Vleeschauwer, Giles Vermeire, Nick Geukens, Paul Declerck
Pagina's: 1431 - 1443
- Intramuscular Electroporation of DNA-Based Monoclonal Antibodies in Sheep: A Translational Model for Clinical Antibody Gene Transfer(2018)
Auteurs: Kevin Hollevoet, Stephanie De Vleeschauwer, Elien De Smidt, Giles Vermeire, Nick Geukens, Paul Declerck
Pagina's: 178 - 179
